europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

EuropaBio Advanced Therapy

28/02/2019
POSITION PAPER
EuropaBio Advanced Therapy

Advanced Therapies Transforming Medicine

What are Advanced Therapy Medicinal Products?
Advanced therapies offer patients new hope against a range of devastating illnesses, such as inherited diseases, leukaemia, blindness, Parkinson’s disease, epilepsy and many others.

Advanced Therapy Medicinal Products are a new generation of innovative medicines based on genes, cells or tissues. Advanced therapies have ground-breaking therapeutic potential, particularly in disease areas where treatment options are absent or inadequate. Excitingly, these therapies are starting to allow us to cure challenging conditions with a one-off treatment. As a result, they also have transformative implications for families, society and healthcare systems.

EuropaBio invites EU decision-makers to engage with us and our healthcare biotech members who are leading the field in advanced therapies.

Download the file below to read the full Factsheet.

EuropaBio Advanced Therapy


Download
Share
Alexandra Simionca
Alexandra Simionca

Related posts

26/04/2023

EuropaBio welcomes the publication of the revision of the EU Pharmaceutical Legislation


Read more
23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more

Important links

  • Biomanufacturing is vital to Europe’s future – EuropaBio’s Biomanufacturing Platform calls for ambition and action
  • SwedenBIO joins EuropaBio: helping innovative companies succeed!

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies